Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Apple Inc.
  6. News
  7. Summary
    AAPL   US0378331005


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Exclusive: EU antitrust regulator seeks input on Microsoft's $16 billion Nuance deal

12/07/2021 | 04:59am EST
FILE PHOTO: A Microsoft logo is seen in Los Angeles

(Reuters) - EU's antitrust regulator is taking a deeper look into Microsoft Corp's $16 billion deal for transcription technology company Nuance Communications Inc, asking customers and competitors to draw up a list of concerns, according to a questionnaire from last month seen by Reuters.

The previously unreported outreach is the most extensive by an antitrust authority since the companies announced the acquisition in April, according to a person familiar with the matter.

Microsoft declined to comment, and Nuance did not respond to a request for comment.

After minimal review, the U.S. Department of Justice in June and the Australian Competition Commission in October said they would not contest the deal. The companies filed for approval from the European Commission's competition bureau last month, and the regulator has until Dec. 21 to clear the deal or open a bigger investigation.

The companies had expected to close the deal by the end of this year, but said last month the timeline could slip to early next year.

The questionnaire asks whether Microsoft and Nuance are competitors and whether a tie-up could affect clients and rivals, including whether Microsoft could favor Nuance over competing services.

Nuance primarily sells transcription technology that is popular among doctors and call centers that want to automate note-talking. Analysts view the deal as bolstering Microsoft's presence in the healthcare market, and bringing it new voice and medical data to train artificial intelligence offerings in health, speech and biometric security.

Like other big tech companies, Microsoft for years has grown its business through acquisitions, such as in advertising and video gaming. But in the last decade, Microsoft has avoided the target that recently has dogged its competitors Alphabet Inc's Google, Facebook Inc, Apple Inc and Amazon.com Inc, all of which are facing antitrust lawsuits and investigations on numerous issues.

Steven Weber, a University of California Berkeley professor studying the intersection of technology and health care, said possible concerns about the pending deal could include Microsoft forcing its Office suite on Nuance customers by bundling them together.

Nuance has said it serves 77% of U.S. hospitals.

A key to its success has been has ensuring in deals with customers that it could use their data to advance its voice recognition systems, according to former chief executive Paul Ricci and another former employee.

For instance, a Nuance contract with Augusta University Medical Center, obtained by Reuters this year through a public records request, reads, "Customer shall provide Nuance access to voice and text data...and grants Nuance a perpetual, royalty-free license to copy, use and analyze such data for speech recognition research."

Big cloud vendors such as Amazon and Microsoft typically do not have unfettered access to customers' data for research and development. But the opportunity to acquire those relationships and data explains Microsoft's interest in Nuance, the former employees said.

Other providers of health transcription technologies include 3M Co and Philips.

(Reporting by Paresh Dave; Editing by Kenneth Li and David Gregorio)

By Paresh Dave

© Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
ALPHABET INC. -2.96% 2538.7 Delayed Quote.-9.70%
AMAZON.COM, INC. -3.15% 2799.72 Delayed Quote.-13.30%
APPLE INC. -1.14% 159.78 Delayed Quote.-8.98%
META PLATFORMS, INC. -2.77% 300.15 Delayed Quote.-8.22%
MICROSOFT CORPORATION -2.66% 288.49 Delayed Quote.-11.88%
NUANCE COMMUNICATIONS, INC. -0.47% 54.79 Delayed Quote.-0.49%
PHILIPS NV 4.05% 29.17 Real-time Quote.-14.44%
All news about APPLE INC.
05:22pEntertainment Co, Boat Rocker, Provides Production Update; Still Expects improved Adjus..
04:06pMicrosoft cloud performance lags highest Wall Street hopes
03:08pApple Set to Report 'Robust' Quarterly Results Despite Chip Shortage, Wedbush Says
03:04pApple's Fiscal Q1 Results Likely Benefited From iPhone Demand But Trajectory Unclear, G..
03:00pSOCIAL BUZZ : Wallstreetbets Stocks Trade Lower; IBM Climbs on Upbeat Q4 Results
02:22pWall Street bounces off session lows as stocks churn ahead of Fed statement
01:01pTech stocks drag Wall Street lower ahead of Fed meeting
11:05aWARREN BUFFETT : Buffett plans in-person Berkshire annual meeting as Omicron wave crests
10:31aWall St slides over 2% as tech rout deepens; Fed meeting eyed
09:07aAPPLE : Share your best iPhone macro photos for Apple's Shot on iPhone Challenge
More news
Analyst Recommendations on APPLE INC.
More recommendations
Financials (USD)
Sales 2022 382 B - -
Net income 2022 93 243 M - -
Net cash 2022 70 007 M - -
P/E ratio 2022 28,2x
Yield 2022 0,58%
Capitalization 2 610 B 2 610 B -
EV / Sales 2022 6,65x
EV / Sales 2023 6,29x
Nbr of Employees 154 000
Free-Float -
Duration : Period :
Apple Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends APPLE INC.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 43
Last Close Price 161,62 $
Average target price 180,21 $
Spread / Average Target 11,5%
EPS Revisions
Managers and Directors
Timothy Donald Cook Chief Executive Officer & Director
Luca Maestri Chief Financial Officer & Senior Vice President
Arthur D. Levinson Independent Chairman
Kevin M. Lynch Vice President-Technology
Jeffrey E. Williams Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
APPLE INC.-8.98%2 639 961
RTX A/S-18.95%198